Your browser doesn't support javascript.
loading
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.
Hyak, Jonathan M; Huang, Ying; Rogers, Kerry A; Bhat, Seema A; Grever, Michael R; Byrd, John C; Kittai, Adam S; Jones, Dan; Miller, Cecelia R; Woyach, Jennifer A.
Afiliação
  • Hyak JM; Department of Medicine and Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
  • Huang Y; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Rogers KA; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Bhat SA; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Grever MR; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Byrd JC; Department of Internal Medicine, The University of Cincinnati, Cincinnati, OH.
  • Kittai AS; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Jones D; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Miller CR; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
  • Woyach JA; Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
Blood Adv ; 6(17): 5124-5127, 2022 09 13.
Article em En | MEDLINE | ID: mdl-35834733
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article